Muna Bhanji - Net Worth and Insider Trading
Muna Bhanji Net Worth
The estimated net worth of Muna Bhanji is at least $2 Million dollars as of 2024-11-05. Muna Bhanji is the Director of Cytokinetics Inc and owns about 17,631 shares of Cytokinetics Inc (CYTK) stock worth over $905,881. Muna Bhanji is the Director of Veracyte Inc and owns about 23,105 shares of Veracyte Inc (VCYT) stock worth over $818,610. Muna Bhanji is also the Director of Intellia Therapeutics Inc and owns about 11,996 shares of Intellia Therapeutics Inc (NTLA) stock worth over $180,360. Details can be seen in Muna Bhanji's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Muna Bhanji has not made any transactions after 2024-06-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Muna Bhanji
Muna Bhanji Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Muna Bhanji owns 4 companies in total, including Cytokinetics Inc (CYTK) , Veracyte Inc (VCYT) , and Ardelyx Inc (ARDX) among others .
Click here to see the complete history of Muna Bhanji’s form 4 insider trades.
Insider Ownership Summary of Muna Bhanji
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYTK | Cytokinetics Inc | 2024-06-10 | director |
| VCYT | Veracyte Inc | 2024-06-10 | director |
| ARDX | Ardelyx Inc | 2021-03-11 | director |
 | | 2023-10-31 | director |
Muna Bhanji Latest Holdings Summary
Muna Bhanji currently owns a total of 3 stocks. Among these stocks, Muna Bhanji owns 17,631 shares of Cytokinetics Inc (CYTK) as of June 10, 2024, with a value of $905,881 and a weighting of 47.56%. Muna Bhanji owns 23,105 shares of Veracyte Inc (VCYT) as of June 10, 2024, with a value of $818,610 and a weighting of 42.98%. Muna Bhanji also owns 11,996 shares of Intellia Therapeutics Inc (NTLA) as of October 31, 2023, with a value of $180,360 and a weighting of 9.47%.
Latest Holdings of Muna Bhanji
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 2024-06-10 | 17,631 | 51.38 | 905,881 |
| VCYT | Veracyte Inc | 2024-06-10 | 23,105 | 35.43 | 818,610 |
| NTLA | Intellia Therapeutics Inc | 2023-10-31 | 11,996 | 15.04 | 180,360 |
Holding Weightings of Muna Bhanji
Muna Bhanji Form 4 Trading Tracker
According to the SEC Form 4 filings, Muna Bhanji has made a total of 2 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Cytokinetics Inc is the sale of 2,000 shares on June 10, 2024, which brought Muna Bhanji around $104,140.
According to the SEC Form 4 filings, Muna Bhanji has made a total of 4 transactions in Veracyte Inc (VCYT) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Veracyte Inc is the sale of 3,870 shares on June 10, 2024, which brought Muna Bhanji around $78,638.
According to the SEC Form 4 filings, Muna Bhanji has made a total of 3 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 265 shares on October 31, 2023, which brought Muna Bhanji around $6,334.
Insider Trading History of Muna Bhanji
- 1
Muna Bhanji Trading Performance
Muna Bhanji Ownership Network
Ownership Network List of Muna Bhanji
Ownership Network Relation of Muna Bhanji
Muna Bhanji Owned Company Details
What does Cytokinetics Inc do?
Who are the key executives at Cytokinetics Inc?
Muna Bhanji is the director of Cytokinetics Inc. Other key executives at Cytokinetics Inc include EVP & Corp. Development & CBO Robert I Blum , SVP Research & Early Dev Fady Ibraham Malik , and VP & Chief Accounting Officer Robert Wong .
Cytokinetics Inc (CYTK) Insider Trades Summary
Over the past 18 months, Muna Bhanji made 2 insider transaction in Cytokinetics Inc (CYTK) with a net sale of 4,000. Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 351,000 shares made by Robert I Blum , a net sale of 194,094 shares made by Fady Ibraham Malik , and a net sale of 40,000 shares made by B Lynne Parshall .
In summary, during the past 3 months, insiders sold 107,136 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 107,136 shares. During the past 18 months, 651,596 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 651,596 shares.
Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytokinetics Inc Insider Transactions
Muna Bhanji Mailing Address
Above is the net worth, insider trading, and ownership report for Muna Bhanji. You might contact Muna Bhanji via mailing address: C/o Cytokinetics, Incorporated, 280 East Grand Avenue, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
